NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.280
+0.020 (1.59%)
Oct 2, 2026, 4:00 PM EDT - Market closed

NanoViricides Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Income
-8.31-8.31-9.59-8.52-8.94-8.11
Net Income
-8.22-8.22-9.47-8.29-8.59-8.11
Earnings Per Share
-0.41-0.41-0.63-0.70-0.74-0.70
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
2.792.791.564.88.1514.07
Total Debt
-----0.09
Net Cash (Debt)
2.792.791.564.88.1513.97
Net Cash Growth
79.27%79.27%-67.52%-41.13%-41.67%-31.58%
Net Cash Per Share
0.140.140.100.400.701.21

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-7.7-7.7-8.48-6.32-5.67-5.89
Capital Expenditures
-0.08-0.08-0.06-0.16-0.15-0.32
Free Cash Flow
-7.78-7.78-8.54-6.47-5.82-6.22
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.